311 related articles for article (PubMed ID: 9382748)
1. Microbiological background for anti-Pseudomonas aeruginosa vaccination in cystic fibrosis.
Bauernfeind A; Przyklenk B
Behring Inst Mitt; 1997 Feb; (98):256-61. PubMed ID: 9382748
[No Abstract] [Full Text] [Related]
2. Vaccinations against Pseudomonas aeruginosa: active and passive alternatives.
Bellanti JA; Zeligs BJ; Kulczycki LL
Pediatr Pulmonol Suppl; 1997; 16():269-70. PubMed ID: 9443307
[No Abstract] [Full Text] [Related]
3. Rationale for development of immunotherapies that target mucoid Pseudomonas aeruginosa infection in cystic fibrosis patients.
Pier GB
Behring Inst Mitt; 1997 Feb; (98):350-60. PubMed ID: 9382760
[TBL] [Abstract][Full Text] [Related]
4. Pseudomonas aeruginosa infection in cystic fibrosis. Relationship between mucoid strains of Pseudomonas aeruginosa and the humoral immune response.
Hoiby N
Acta Pathol Microbiol Scand B Microbiol Immunol; 1974 Aug; 82(4):551-8. PubMed ID: 4213330
[No Abstract] [Full Text] [Related]
5. Antibody responses induced by long-term vaccination with an octovalent conjugate Pseudomonas aeruginosa vaccine in children with cystic fibrosis.
Zuercher AW; Horn MP; Que JU; Ruedeberg A; Schoeni MH; Schaad UB; Marcus P; Lang AB
FEMS Immunol Med Microbiol; 2006 Jul; 47(2):302-8. PubMed ID: 16831219
[TBL] [Abstract][Full Text] [Related]
6. Pseudomonas aeruginosa and cystic fibrosis: intrastrain variability in relation to intensity of immune response and clinical outcome.
Quentin R; Bollet C; Dayan A; Martin C; Goudeau A; De Micco P
New Microbiol; 1993 Apr; 16(2):185-8. PubMed ID: 8510574
[TBL] [Abstract][Full Text] [Related]
7. Early aggressive eradication therapy for intermittent Pseudomonas aeruginosa airway colonization in cystic fibrosis patients: 15 years experience.
Hansen CR; Pressler T; Høiby N
J Cyst Fibros; 2008 Nov; 7(6):523-30. PubMed ID: 18693078
[TBL] [Abstract][Full Text] [Related]
8. Pseudomonas agglutinins in patients with cystic fibrosis.
Habboushe C; Iacocca V; Braddock L; Barbero G
Pediatrics; 1971 Dec; 48(6):973-4. PubMed ID: 5001974
[No Abstract] [Full Text] [Related]
9. Prevention of Pseudomonas aeruginosa infection in cystic fibrosis patients.
Döring G
Int J Med Microbiol; 2010 Dec; 300(8):573-7. PubMed ID: 20940108
[TBL] [Abstract][Full Text] [Related]
10. Pseudomonas aeruginosa and Burkholderia cepacia cannot be detected by PCR in the breath condensate of patients with cystic fibrosis.
Vogelberg C; Hirsch T; Rösen-Wolff A; Kerkmann ML; Leupold W
Pediatr Pulmonol; 2003 Oct; 36(4):348-52. PubMed ID: 12950050
[TBL] [Abstract][Full Text] [Related]
11. The combination of PCR and serology increases the diagnosis of Pseudomonas aeruginosa colonization/infection in cystic fibrosis.
da Silva Filho LV; Tateno AF; Martins KM; Azzuz Chernishev AC; Garcia Dde O; Haug M; Meisner C; Rodrigues JC; Döring G
Pediatr Pulmonol; 2007 Oct; 42(10):938-44. PubMed ID: 17722007
[TBL] [Abstract][Full Text] [Related]
12. [Isolated pathogen microorganisms in respiratory samples from children with cystic fibrosis].
Anzaudo MM; Busquets NP; Ronchi S; Mayoral C
Rev Argent Microbiol; 2005; 37(3):129-34. PubMed ID: 16323660
[TBL] [Abstract][Full Text] [Related]
13. Selective oral decontamination in cystic fibrosis: an attempt to prevent pseudomonas colonisation.
Dalzell AM; van Saene HK; Heaf DP
Acta Univ Carol Med (Praha); 1990; 36(1-4):40-1. PubMed ID: 2130715
[No Abstract] [Full Text] [Related]
14. Bacteriological studies of bronchial secretions in 19 cases of cystic fibrosis.
Feigelson J; Pecau Y
Bibl Paediatr; 1967; 86():214-26. PubMed ID: 4964164
[No Abstract] [Full Text] [Related]
15. A multicenter vaccine trial using the Pseudomonas aeruginosa flagella vaccine IMMUNO in patients with cystic fibrosis.
Döring G; Dorner F
Behring Inst Mitt; 1997 Feb; (98):338-44. PubMed ID: 9382758
[TBL] [Abstract][Full Text] [Related]
16. Vaccination promotes TH1-like inflammation and survival in chronic Pseudomonas aeruginosa pneumonia. A new prophylactic principle.
Johansen HK; Cryz SJ; Hougen HP; Moser C; Høiby N
Behring Inst Mitt; 1997 Feb; (98):269-73. PubMed ID: 9382750
[TBL] [Abstract][Full Text] [Related]
17. [Anti-pseudomonas-specific precipitins as a marker of chronic infection in patients with cystic fibrosis].
Castello D; Mari C; Visca A
Minerva Pediatr; 1999 Mar; 51(3):47-51. PubMed ID: 10368566
[TBL] [Abstract][Full Text] [Related]
18. Approaches to the treatment of initial Pseudomonas aeruginosa infection in children who have cystic fibrosis.
Lahiri T
Clin Chest Med; 2007 Jun; 28(2):307-18. PubMed ID: 17467550
[TBL] [Abstract][Full Text] [Related]
19. Cystic fibrosis and pseudomonas infection.
Lancet; 1983 Jul; 2(8344):257-8. PubMed ID: 6135081
[No Abstract] [Full Text] [Related]
20. Serogroups of Pseudomonas aeruginosa and the immune response of patients with cystic fibrosis.
Diaz E; Mosovich LL; Neter E
J Infect Dis; 1970 Mar; 121(3):269-74. PubMed ID: 4984335
[No Abstract] [Full Text] [Related]
[Next] [New Search]
